Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Unknown 3Terminated 3Withdrawn 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 3Skin Diseases 2Precancerous Conditions 2Keratosis, Actinic 2The Aim of the Study is to Evaluate the Efficacy of Photodynamic Therapy as an 1Squamous Intraepithelial Lesions 1Skin Neoplasms 1Ovarian Neoplasms 1Non-Melanoma Skin Cancer (NMSC) 1Neurofibromatosis 1 1Neurofibroma 1Kidney Neoplasms 1Glioma 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 19Temozolomide 16Radiotherapy 10Specimen Handling 7Blood Specimen Collection 7Radiation 6Bevacizumab 5Nivolumab 4Cyclophosphamide 4Biopsy 4vorasidenib 3trametinib 3pembrolizumab 3olaparib 3fludarabine 3dabrafenib 3Watchful Waiting 3Surgical Procedures, Operative 3Magnetic Resonance Imaging 3Drug Therapy 3olutasidenib 2lutetium Lu 177 dotatate 2fluorodopa F 18 2fluciclovine F-18 2entrectinib 2contrast agent BR1 2Restraint, Physical 2Radiosurgery 2Microdialysis 2Flucytosine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Glioma × Aminolevulinic Acid × Clear all
NCT02691923 2025-08-03

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
30 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡